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PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; s.e.m., standard error of the 
mean; Tm, melting temperature. 
 
 
Abstract 
In eukaryotic cells, cytoplasmic mRNA is characterised by a 3’ poly(A) tail. The shortening and 
removal of poly(A) tails (deadenylation) by the Ccr4-Not nuclease complex leads to reduced 
translational efficiency and RNA degradation. Using recombinant human Caf1 (CNOT7) enzyme as a 
screening tool, we recently described the discovery and synthesis of a series of substituted 1-
hydroxy-3,7-dihydro-1H-purine-2,6-diones (1-hydroxy-xanthines) as inhibitors of the Caf1 catalytic 
subunit of the Ccr4-Not complex. Here, we used a chemiluminescence-based AMP detection assay to 
show that active 1-hydroxy-xanthines inhibit both isolated Caf1 enzyme and human Caf1-containing 
complexes that also contain the second nuclease subunit Ccr4 (CNOT6L) to a similar extent, 
indicating that the active site of the Caf1 nuclease subunit does not undergo substantial 
conformational change when bound to other Ccr4-Not subunits. Using differential scanning 
fluorimetry, we also show that binding of active 1-hydroxy-xanthines requires the presence of Mg2+ 
ions, which are present in the active site of Caf1.  
 
Introduction 
In eukaryotes, cytoplasmic mRNA is characterized by the presence of a 3' poly(A) tail. 
Poly(A) tail length is broadly distributed with the median length varying from 27-28 
nucleotides in yeast, to 40-100 nucleotides in mammalian cells [1,2]. The poly(A) tail 
contributes to mRNA stability and translational efficiency and the removal of the poly(A) tail 
is an important step in regulated mRNA degradation [3,4]. A key multi-subunit enzyme 
complex involved in the controlled removal of the poly(A) tail is the Ccr4-Not deadenylase 
complex that is composed of two catalytic nuclease subunits and six non-catalytic 
components. In mammalian cells, the large subunit CNOT1 is the scaffold of the complex 
[5,6]. Its N-terminal domain interacts with CNOT11 and CNOT10, whose function is not 
well understood [6,7]. The MIF4G domain of CNOT1 is part of the nuclease module and 
binds to the Caf1 catalytic subunit (encoded by either CNOT7 or CNOT8), which in turn 
interacts with the leucine-rich repeat domain of the second catalytic subunit Ccr4 (encoded 
by CNOT6 or CNOT6L) [8,9]. The DUF3819 domain of CNOT1 binds to CNOT9 [10,11], 
while the C-terminal region of CNOT1 interacts with the CNOT2 and CNOT3 subunits 
forming the NOT-module [12,13]. The non-catalytic subunits stimulate the activity of the 
nuclease module [14,15] and form a platform for interactions with regulators of mRNA 
stability, including the GW182/TNRC6 component of the microRNA repression complex 
[16,17], and the A/U-rich element binding protein tristetraprolin TTP (ZFP36) [18-20]. Using 
genetically modified mice, specific physiological roles for a number of Ccr4-Not components 
have been uncovered. The Caf1 nuclease subunit encoded by the Cnot7 gene regulates bone 
formation by inhibiting osteoblast activity [21] and is also required for male fertility [22,23]. 
Deletion of one copy of Cnot3, a non-catalytic subunit of Ccr4-Not, protects against obesity 
in mice [24]. Mutations in Ccr4-Not components have also been implicated in human disease. 
Nonsense mutations in CNOT3 are associated with acute lymphoblastic leukaemia, whereas a 
recurrent missense mutation in CNOT9 is found in metastatic melanoma [25,26]. 
Furthermore, mouse models of breast cancer have implicated Ccr4-Not components in 
promoting metastatic cancer [27,28]. In case of Caf1, its enzymatic activity is required for 
this effect indicating that Caf1 inhibitors may be useful pharmacological tools to validate this 
protein as a possible drug target to prevent metastatic breast cancer [28].  
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Although much progress has been made in the past few years, the mechanism of poly(A) 
deadenylation by Caf1 and Ccr4 is still not fully understood. The Caf1 subunit, which contains an 
RNAse D/DEDD (Asp-Glu-Asp-Asp) nuclease domain, appears dispensable in budding yeast, but 
makes a contribution to the activity of the complex in fission yeast and the fruit fly [29-31]. On the 
other hand, the second catalytic nuclease subunit, the EEP (endonuclease-exonuclease-phosphatase) 
domain protein Ccr4, is the catalytic subunit in budding yeast and –like Caf1– contributes to the 
activity in fission yeast and Drosophila [15,32-34]. The situation is more complex in human cells, 
where both Caf1 and Ccr4 appear to be required for activity of the nuclease module, which has 
much increased activity as compared to either the isolated Caf1 or Ccr4 subunit [35]. Moreover, it 
has been proposed that the Caf1 and Ccr4 subunits have specialised roles, with Ccr4 required for the 
degradation of poly(A) bound by the poly(A)-binding protein PABPC1, which inhibits the activity of 
Caf1 [36,37]. On the other hand, it has been reported that the highly similar proteins BTG1 and BTG2 
can mediate interactions between PABPC1 and Caf1 thereby promoting deadenylation by Caf1 [38]. 
 
Recently, we reported the discovery and synthesis of a series of substituted 1-hydroxy-3,7-dihydro-
1H-purine-2,6-dione (1-hydroxy-xanthine) compounds as the first non-nucleoside inhibitors of Caf1 
[39]. Here, we report the further biochemical characterisation of these compounds by using two 
assays: (i) a chemiluminescence-based assay for the detection of AMP, the product of the 
deadenylation reaction; and (ii) differential scanning fluorimetry (thermal shift assay). Using these 
assays, we demonstrate that the 1-hydroxy-xanthine compounds inhibit the isolated human Caf1 
enzyme with the same potency as human Caf1-containing complexes that also contain the second 
catalytic subunit Ccr4. This suggest that the active site of Caf1 does not undergo substantial 
conformational changes when incorporated into the Ccr4-Not complex. In addition, we show that 
active 1-hydroxy-xanthines require the presence of Mg2+ ions for binding, which provides 
experimental support for the proposed role of the N-hydroxyimide moiety in coordinating Mg2+ ions 
present in the active site of Caf1. These experiments also demonstrate the value of the 
chemiluminescence-based AMP detection assay and differential scanning fluorimetry as useful 
orthogonal assays that supplement our previously reported fluorescence-based FRET assay [40] for 
the discovery and characterisation of inhibitors of the Caf1 nuclease enzyme.  
 
Materials and methods 
Reagents 
1-Hydroxy-xanthine compounds 1-5 were described previously [39]. The human Caf1/CNOT7 
enzyme was expressed and purified from Escherichia coli BL21 (DE3) using procedures described 
before [40]. The trimeric human nuclease module (BTG2-Caf1/CNOT7-Ccr4/CNOT6L) was obtained 
by co-expression of the three proteins using plasmids pQE80L-BTG2 and pACYC-Duet1-Strep-
CNOT6L-CNOT7 and purified as described before [14,35]. The human pentameric central module 
(BTG2-Caf1/CNOT7-Ccr4/CNOT6L-CNOT1-CNOT9) of Ccr4-Not was obtained by reconstitution of the 
complex after separate expression and purification of the nuclease module and the dimeric complex 
composed of CNOT1 (MIF4G and DUF3819 domains; amino acids 1093-1595) and CNOT9 (ARM 
domain; amino acids 33-283) using plasmid pACYC-Duet1-CNOT1-CNOT9 as described before [14]. 
 
Enzyme activity assays 
Standard reaction conditions for deadenylase assays (10 µl) were: 25 nM enzyme, 20 mM Tris-HCl 
pH 7.9, 50 mM NaCl, 2 mM MgCl2, 10% glycerol, 1 mM β-mercaptoethanol and 1.0 µM 5’-Flc-labelled 
RNA substrate in nuclease-free water as described before [40]. Reactions containing inhibitory 
compounds also contained 5% DMSO. After incubation at 30C for 60 min, chemiluminescence-
based detection of AMP was carried out using the AMP-Glo kit (Promega) [41-43]. To this end, 5 µl of 
the enzyme reaction was mixed with an equal volume of AMP-Glo reagent I in a white 96-well half-
area multi-well plate (Corning Costar, reference 3693). After a further 60 min incubation at room 
temperature, 10 µl AMP-Glo reagent II was added. After another 60 min incubation at room 
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temperature, chemiluminescence was measured using a GloMax 96 multiwell plate luminometer 
(Promega). Data was exported to Microsoft Excel 2013 and analysed using Graphpad Prism (version 
7). 
 
Differential scanning fluorimetry 
Differential scanning fluorimetry (thermal stability assay) was carried out as described with minor 
modifications using an Agilent MX3005p instrument and the fluorescent dye SYPRO Orange (5000 
in DMSO, ThermoFisher Scientific) [44]. Standard assays (20 µl) contained: 2 µM purified 
Caf1/CNOT7 enzyme, 20 mM Tris-HCl pH 7.8, 50 mM NaCl, 10% glycerol, 1 mM β-mercaptoethanol, 
0.2× SYPRO Orange dye, 100  µM compound, 5% DMSO. Assays carried out in the presence of 
divalent metal ions also contained 2 mM MgCl2.  
 
Reactions were performed in thin-wall, PCR grade 96-well plates with V-shaped wells. After sealing 
using optically clear lids, reactions were thoroughly mixed and collected at the bottom of the wells 
by centrifugation. Fluorescence scanning was carried out using a temperature gradient from 25°C to 
95°C at 1°C per minute using the FAM (492 nm) filter for excitation and the ROX (610 nm) filter for 
detection. Each experiment contained three technical replicates. Data were acquired using MxPro 
QPCR software (Agilent), exported to Microsoft Excel 2013 and analysed using publicly available 
macros for Microsoft Excel 2013 and templates for Graphpad Prism (version 7) as described [44]. 
 
Statistical analysis 
Standard errors of the mean were calculated using Graphpad Prism (version 7). Reported IC50 values 
were determined based on at least three independent experiments each containing at least two 
technical replicates. Reported ΔTm values were calculated based on at least three independent 
experiments, each containing three technical replicates. P values were calculated using a two-tailed 
t-test (Graphpad Prism, version 7). 
 
Results and discussion 
Chemiluminescence-based detection of AMP as a sensitive assay for deadenylase activity 
To determine the activity of 1-hydroxy-xanthine compounds (Fig. 1) versus human Caf1 and Caf1-
containing complexes that also contain the second catalytic subunit Ccr4, we first purified the 
isolated Caf1 protein, which displays relatively weak deadenylase activity, the trimeric BTG2-Caf1-
Ccr4 nuclease module, which displays relatively robust nuclease activity, and the pentameric central 
module, which displays relatively high enzymatic activity (Fig. 2A). The proteins were expressed in 
Escherichia coli and were purified using affinity chromatography as described before (Fig. 2B) 
[14,35,40]. We then evaluated the use of chemiluminescence-based detection of AMP [41-43] as an 
activity assay of Caf1 and Caf1-containing complexes. We chose this assay as a potential assay that is 
complementary to the fluorescence-based assay described before (Fig. 2C) [40]. Importantly, the 
AMP detection assay is suitable for multi-well plates, allowing the analysis of many compounds in 
parallel, and does not depend on time-consuming analysis of reaction products by gel 
electrophoresis.  
 
We used a synthetic 15-mer RNA oligonucleotide with nine adenosines at the 3’ end as the enzyme 
substrate [40]. After incubation with varying concentrations of the Caf1 enzyme, AMP was detected 
in a two-step procedure. In the first step, AMP was enzymatically converted to ADP. Then, enzymatic 
conversion of ADP to ATP in the presence of luciferase and luciferin resulted in chemi-luminescence 
proportional to the amount of AMP produced in the reaction. Robust levels of AMP were detected at 
enzyme concentrations below 100 nM, which is substantially lower as compared to the amount of 
enzyme required for the fluorescence-based assay (Fig. 2D, 2E) [40]. Only very low levels of AMP 
were produced in the presence of the catalytically inactive variant D40A and a signal/background 
ratio >10 was achieved at wild-type enzyme concentrations >25 nM (Fig. 2D, 2E). When the activity 
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of Caf1-containing complexes was determined, much increased levels of AMP were detected in 
agreement with our previous findings that the activity of the nuclease and central modules of Ccr4-
Not display higher activity than the isolated Caf1 subunit [14,35]. The activity determined in the 
presence of Caf1-containing complexes was specific, because only very low levels of AMP were 
detected in the presence of Caf1-containing complexes with inactive Caf1 (D40A) and Ccr4 (E240A) 
catalytic subunits. 
 
Together, these experiments demonstrate that chemiluminescence-based detection of AMP is a 
highly sensitive assay that is suitable for the evaluation of the enzymatic activity of Caf1 and Caf1-
containing complexes. 
 
1-Hydroxy-xanthine compounds inhibit Caf1 and Caf1-containing complexes with similar potency 
To test whether the assay can be used as a quantitative assay for the characterisation of small-
molecule inhibitors, we next determined the IC50 value of five 1-hydroxy-xanthine compounds 1-5, 
which were previously characterised using the fluorescence-based assay and inhibit Caf1 with IC50 
values ranging from 0.59 ± 0.11 µM to 10.4 ± 0.4 µM (Fig. 1 and Table 1) [39]. Importantly, these 
compounds do not display activity towards the catalytic domain of Ccr4 [39]. To determine the IC50 
values, we used conditions where the reaction product increased proportionally with time and 
substrate concentrations were not limiting (Fig. 2E, t = 60 min). As shown in Fig. 3A and Table 1, the 
IC50 values determined using chemiluminescence-based AMP detection closely matched the values 
previously obtained using the fluorescence-based assay. Based on these results, we conclude that 
both assays are suitable for the characterisation of the activity of compounds that inhibit 
deadenylase enzymes and result in comparable IC50 values.  
 
To determine whether our recently developed series of 1-hydroxy-xanthines inhibit Caf1-containing 
complexes with similar potency compared to the isolated Caf1 subunit, we next determined the 
activity of compounds 1-5 versus the trimeric nuclease module and the pentameric central module 
of the Ccr4-Not complex (Fig. 3B and 3C). As shown in Fig. 3 and Table 1, the selected 1-hydroxy-
xanthines displayed similar activity versus the trimeric nuclease module (Fig. 3B) as well as the 
pentameric central module (Fig. 3C). These results indicate that the active site of the isolated Caf1 
subunit does not undergo substantial conformational changes upon association with other Ccr4-Not 
subunits, including the Ccr4 ribonuclease subunit, whose leucine-rich repeat (LRR) domain interacts 
directly with the Caf1/CNOT7 subunit, or the CNOT1 subunit, which binds to Caf1 via the MIF4G 
domain. Moreover, the compounds fully inhibited the activity of Caf1 and the Caf1-containing 
nuclease complexes showing that the Caf1 subunit is indispensable for deadenylase activity in the 
context of the nuclease and central modules, even in the presence of the second catalytic nuclease 
subunit Ccr4.  
 
1-hydroxy-xanthine compounds require the presence of Mg2+ ions for binding 
Having established that 1-hydroxy-xanthines inhibit Caf1 and Caf1-containing complexes with similar 
potency, we next aimed to obtain further information about their mode of binding. Specifically, we 
aimed to establish if binding of 1-hydroxy-xanthines requires the presence of Mg2+ ions in the active 
site as suggested by our proposed binding mode [39] or that of related compounds containing an 
N-hydroxyimide moiety to the Influenza endonuclease PA protein and the human DNA structure-
specific endonuclease FEN-1 [45-48]. To this end, we evaluated the use of differential scanning 
fluorimetry (DSF), which is based on increased thermal stability of a protein induced upon binding of 
small-molecule ligands [44,49,50]. First, we determined the melting temperature Tm of Caf1 in the 
absence and presence of MgCl2 and observed a robust increase in the Tm of Caf1 in the presence of 
Mg2+ ions (Fig. 4; ΔTm = 3.9 ± 0.2C; mean ± s.e.m., n = 7). Encouraged by these results, we then 
carried out DSF using Caf1 in the presence of 1-hydroxy-xanthines 1-5. In the absence of MgCl2, no 
significant changes in the melting temperatures were observed in the presence of compounds 1-5 as 
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compared to enzyme only (P > 0.05; Table 1 and Fig. 5). By contrast, significant changes in the 
thermal shifts were observed in the presence of compound 1-5 and MgCl2 as compared to control 
reactions containing enzyme and MgCl2 only (P < 0.05). These observations suggest that binding of 1-
hydroxy-xanthines requires the presence of Mg2+ ions, which are present in the active site of Caf1.  
 
Correlation between thermal shifts and IC50 values 
Because it has been shown that thermal shift assays can provide quantitative information about the 
binding affinity of enzyme ligands [50], we next considered whether the observed thermal shifts 
correlated with the IC50 inhibitory concentrations of compounds 1-5. To this end, we plotted the Tm 
values observed in the presence of MgCl2 against the corresponding IC50 values. As shown (Fig. 6), 
we found a high correlation between the Tm values and the pIC50 values obtained using the isolated 
Caf1 enzyme (r2 = 0.90 using the fluorescence-based FRET assay and r2 = 0.78 using the 
chemiluminescence-based AMP detection assay). This indicates that the observed thermal shifts 
provide quantitative information about the relative potency of compounds 1-5 (Fig. 6) versus the 
Caf1 nuclease. Thus, we show that differential scanning fluorimetry is not only useful to provide 
information about the binding mode of Caf1 inhibitors, but may also be used as an additional 
screening tool to characterise and identify new compounds that inhibit the Caf1 nuclease. 
 
In summary, the results reported here provide insight into the mechanism of inhibition of the Caf1 
deadenylase enzyme by 1-hydroxy-xanthines. First, we show that compounds 1-5 inhibit the isolated 
enzyme with similar potency as Caf1-containing complexes, which also include the Ccr4 nuclease 
subunit. It is notable that the activity of the Caf1-containing complexes was completely inhibited at 
higher compound concentrations, even though the compounds do not affect Ccr4 [39]. This indicates 
that Caf1 is essential for the activity of complexes containing both Caf1 and Ccr4 nucleases. The 
observation that the nuclease complexes can be inhibited by small molecules extends our previously 
reported findings, which showed that the activity of the human BTG2-Caf1-Ccr4 nuclease complex 
requires the activity of both Caf1 and Ccr4, and that inactivating amino acid substitutions in either 
Caf1 or Ccr4 are sufficient to abolish the activity of the complex [35]. This contrasts with the finding 
that Caf1 activity is not essential for the activity of complexes containing the Caf1 and Ccr4 nucleases 
from the fission yeast S. pombe and the fruit fly Drosophila and residual activity is observed upon 
inactivation of Caf1 in those cases [15,33]. Secondly, we showed that binding of compounds 1-5 
requires the presence of Mg2+ ions, which bind in the active site of Caf1. This is in agreement with 
the proposed role of the N-hydroxyimide moiety in 1-hydroxy-xanthines and related compounds 
forming ion–dipole interactions with the Mg2+ ions [45-48].  
In addition to these findings, two further assays for the evaluation of Caf1 inhibitors are presented 
here. The chemiluminescence-based detection of AMP provides an orthogonal assay for our 
previously reported fluorescence-based assay that does not depend on gel-based product analysis. 
While the AMP-detection method has some disadvantages, including the relative instability of the 
signal and the dependence on an enzymatic cascade for detection of AMP, which requires additional 
time-consuming incubation steps, it benefits from increased sensitivity, a greater dynamic range and 
increased signal-to-noise ratios. In addition, we show that the widely used thermal shift assay is 
suitable for the analysis of inhibitor binding to Caf1 and also provides information about the binding 
mode of the inhibitor-enzyme complexes. 
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Cmpd 
IC50 (µM) 
vs 
Caf1 
(Reference)a 
IC50 (µM)
 
vs 
Caf1b 
 
IC50 (µM) 
vs 
trimeric 
Caf1-
complexc 
IC50 (µM) 
vs 
pentameric 
Caf1-
complexd 
Differential scanning 
fluorimetry 
ΔTm (C) 
Caf1 
(no MgCl2)
e 
ΔTm (C) 
 Caf1 
(MgCl2)
f 
1 10.4 ± 0.4 12.7 ± 0.9 13.6 ± 0.6 10.8 ± 0.2 -0.4 ± 0.3 2.4 ± 0.3 
2 1.5 ± 0.3 3.2 ± 0.4 2.3 ± 0.2 2.6 ± 0.3 0.6 ± 0.4 4.1 ± 0.3 
3 2.1 ± 0.3 2.7 ± 0.3 2.4 ± 0.2 2.4 ± 0.1 0.5 ± 0.5 3.3 ± 0.2 
4 1.7 ± 0.4 2.2 ± 0.3 2.2 ± 0.1 2.5 ± 0.4 0.6 ± 0.6 3.4 ± 0.4 
5 0.59 ± 0.11 0.79 ± 0.09 1.0 ± 0.2 0.98 ± 0.07 -0.2 ± 0.3 4.7 ± 0.3 
 
Table 1. Activity of 3,7-disubstituted-1-hydroxy-1,7-dihydro-1H-purine-2,6-diones. a IC50 values 
determined using a fluorescence-based assay were taken from Jadhav et al [39].  b IC50 values were 
determined using chemiluminescence-based AMP detection in the presence of monomeric 
Caf1/CNOT7 enzyme. c IC50 values were determined using chemiluminescence-based AMP detection 
in the presence of trimeric BTG2-Caf1-Ccr4 nuclease module. d IC50 values were determined using 
chemiluminescence-based AMP detection in the presence of pentameric BTG2-Caf1-Ccr4-CNOT1-
CNOT9 central module. eDifferential scanning fluorimetry. ΔTm values were determined by 
differential scanning fluorimetry in the presence of Caf1/CNOT7 and the indicated compound. 
fDifferential scanning fluorimetry. ΔTm values were determined by differential scanning fluorimetry 
in the presence of Caf1/CNOT7, 2 mM MgCl2 and the indicated compound. Indicated are the 
mean ± standard error of the mean (n = 3).  
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Figure legends 
 
Fig. 1. Structure of 1-hydroxy-xanthine derivatives 1-5. 
 
Fig. 2. Application of a chemiluminescence-based AMP detection system as a quantitative assay for 
deadenylation activity. (A) Schematic overview of Caf1 and Caf1-containing complexes. (B) Purified 
recombinant Caf1 and Caf1-containing complexes. WT, wild type; M, mutant protein preparations 
containing the D40A amino acid substitution in Caf1 or the D40A substitution in Caf1 and the E240A 
substitution in Ccr4 (nuclease and central modules). Left panel, Purified proteins (5 µg) were 
separated by 14% SDS-PAGE and stained with Coomassie Brilliant Blue. Right panel, Purified proteins 
(20 µg) were separated by 14% SDS-PAGE and stained with Coomassie Brilliant Blue. (C) Schematic of 
the deadenylation reaction and the use of activity assays based on RNA substrate (left) and AMP 
product (right) detection. The fluorescence-based assay was described before [40]. (D) Activity of 
Caf1 and Caf1-containing complexes using chemi-luminescence-based AMP detection. Protein 
samples were incubated with a synthetic RNA substrate at 30C for 60 min before the detection of 
AMP levels. (E) Time-course analysis of Caf1 and Caf1-containing complexes. Protein samples (25 
nM) were incubated with a synthetic RNA substrate containing 9 terminal adenosine residues (1.0 
µM) at 30C. A.U., arbitrary units. Error bars represent the standard error of the mean (n = 3). 
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2019) © 2019 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd. 
 
Fig. 3. Inhibition of Caf1 and Caf1-containing complexes by 1-hydroxy-xanthines. (A) Inhibition of the 
isolated Caf1 subunit. (B) Inhibition of a trimeric BTG2-Caf1-Ccr4 nuclease module of Ccr4-Not. (C) 
Inhibition of a pentameric BTG2-Caf1-Ccr4-CNOT1-CNOT9 central module of Ccr4-Not. Enzyme 
preparations (25 nM) were incubated with a synthetic RNA substrate containing nine terminal 
adenosine residues (1.0 µM) at 30C for 60 min. Error bars represent the standard error of the mean 
(n = 3). 
 
Fig. 4. Increased thermal stability of Caf1 in the presence of Mg2+ ions.  (A) Differential scanning 
fluorimetry of Caf1 in the absence and presence of MgCl2. Caf1 (2 µM) was incubated in the absence 
or presence of 2 mM MgCl2 and the SYPRO Orange dye. Fluorescence scanning was carried out using 
a temperature gradient from 25°C to 95°C. The melting temperature Tm was determined as 
described [44]. (B) Thermal stability of Caf1 in the absence and presence of MgCl2. ΔTm = 3.9 ± 0.2C; 
mean ± s.e.m. (n = 7). Error bars indicate the standard error of the mean (n = 7).  
 
Fig. 5. Binding of 1-hydroxy-xanthines requires the presence of Mg2+ ions. (A-E) Representative 
experiments showing binding of compounds 1-5 to Caf1 in the absence of Mg2+ (left panels) and 
2 mM MgCl2 (right panels). Compounds (100 µM) were incubated with Caf1 (2 µM) and the SYPRO 
Orange dye. Fluorescence scanning was carried out using a temperature gradient from 25°C to 95°C. 
The melting temperature Tm was determined as described [44].  
 
Fig. 6. Correlation between thermal shifts (Tm) observed in the presence of MgCl2 and inhibitory 
activity of compounds 1-5. (A) Correlation between thermal shift and pIC50 values determined using 
the isolated Caf1 protein and the fluorescence-based assay (r2 = 0.90). (B) Correlation between 
thermal shift and pIC50 values determined using the isolated Caf1 protein and the 
chemiluminescence-based AMP detection assay (r2 = 0.78). Linear regression was carried out using 
GraphPad Prism (version 7.0).  
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